Wyeth Pharmaceuticals U.S. President Geno Germano: An Interview With “The Pink Sheet” DAILY
This article was originally published in The Pink Sheet Daily
Executive Summary
Exec discusses Wyeth's selling model and how the firm is planning for potential launches this year of products like Pristiq and Torisel.
You may also be interested in...
Wyeth Suggests Pristiq Could Surpass Effexor XR In Depression Market
Combined global market for major depressive disorder and vasomotor symptoms represents 35 million women, firm says during Goldman Sachs investor conference.
Wyeth Suggests Pristiq Could Surpass Effexor XR In Depression Market
Combined global market for major depressive disorder and vasomotor symptoms represents 35 million women, firm says during Goldman Sachs investor conference.
Torisel Action Date Extended To July 5
FDA will use extension to examine new tumor evaluation information submitted by Wyeth.